Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
// Rongrong Liu 1,2,* , Agnieszka D. Truax 2,* , Liang Chen 2 , Peizhen Hu 3 , Zengshan Li 3 , Jun Chen 4 , Chaojun Song 1 , Lihua Chen 1 and Jenny Pan-Yun Ting 2,5 1 Department of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi’an, China 2 The Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 3 Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi’an, China 4 Department of Encephalopathy, Traditional Chinese Medicine Hospital of Shan Xi Province, Xi’an, China 5 Departments of Genetics, Microbiology-Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA * These authors have contributed equally to the work Correspondence to: Jenny Pan-Yun Ting, email: // Lihua Chen, email: // Keywords : NLRs, AIM2, FFPE, colorectal cancer, inflammasome Received : August 02, 2015 Accepted : August 20, 2015 Published : September 10, 2015 Abstract NLRs (nucleotide-binding domain leucine-rich repeat proteins or NOD-like receptors) are regulators of inflammation and immunity. A subgroup of NLRs and the innate immune receptor, AIM2 (absent-in-melanoma 2), can induce the assembly of a large caspase-1 activating complex called the inflammasome. Other NLRs regulate key signaling pathways such as NF-kB and MAPK. Since inflammation is a central component of colorectal cancer (CRC), this work was undertaken to analyze NLR and AIM2 expression in human CRC by combining bioinformatics analysis and experimental verification using clinical tissue samples. Additional experiments analyzed the association of (i) gene expression and cancer staging, and (ii) gene expression among inflammasome components. Ten public CRC datasets from the Oncomine ® Platform were analyzed. Genes analyzed include NLRP1, NLRP3, NLRP6, NLRP12, NLRC3, NLRC4, NLRC5, NOD1, NOD2 and AIM2. Additionally, forty case-matched cancer samples and adjacent healthy control tissues isolated from a cohort of Chinese CRC patients were profiled. Three patterns of gene expression in CRC are shown. The expression of NLRC3, a checkpoint of inflammation, and the inflammasome components NLRP1, NLRP3, NLRC4 and AIM2 were reduced in CRC. NOD1 and NOD2 expression was increased in CRC, while NLRC5, NLRP6 and NLRP12 showed little difference compared to controls. Reduced expression of NLRC3 in CRC was verified in all available databases analyzed and confirmed with our patient cohort. Furthermore, the extent of NLRC3 and AIM2 gene reduction was correlated with cancer progression. This report reveals the potential value of NLR and AIM2 genes as biomarkers of CRC and cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Inflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340
Self-citationNLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Wlodarska, M., Thaiss, C. A., Nowarski, R., Henao-Mejia, J., Zhang, J.-P., Brown, E. M., Frankel, G., Levy, M., Katz, M. N., Philbrick, W. M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.026 · Cited by 708
Inflammasomes in carcinogenesis and anticancer immune responses
Zitvogel, L., Kepp, O., Galluzzi, L., & Kroemer, G. (2012) · Nature Immunology · doi:10.1038/ni.2224 · Cited by 593 · cited 1×
“Functionally, it is a potent pro-inflammatory cytokine associated with tumor growth and angiogenesis [24].”
BackgroundZaki, M. H., Vogel, P., Body-Malapel, M., Lamkanfi, M., & Kanneganti, T.-D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002046 · Cited by 411 · cited 1×
“However, in models of colitis-associated colorectal cancer IL-18 cytokine addback showed that IL-18 protected against tumor [28].”
Hong, Y., Downey, T., Eu, K. W., Koh, P. K., & Cheah, P. Y. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9305-4 · Cited by 319 · cited 1×
“Gene lists based on fold change were obtained from ten CRC datasets which were named by the convention based on the first author and numbers of patient (CRC/normal controls) as follows: Gaedcke [65/65] [36], Skrzypczak [81/24] [37], Hong [70/12] [38], TCGA colon cancer [215/22] [18], Kaiser [100/5] [39], Graudens [18/…”
Method
Cited by
Diverging inflammasome signals in tumorigenesis and potential targeting
Karki, R., & Kanneganti, T.-D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0123-y · Cited by 641
Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
Man, S. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0054-1 · Cited by 302
Harnessing innate immune pathways for therapeutic advancement in cancer
Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 255
The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma
Feng, X., Luo, Q., Zhang, H., Wang, H., Chen, W., Meng, G., & Chen, F. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0553-x · Cited by 170
NLRP6: A Multifaceted Innate Immune Sensor
Levy, M., Shapiro, H., Thaiss, C. A., & Elinav, E. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.001 · Cited by 127
Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy
Drewes, J. L., Housseau, F., & Sears, C. L. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.189 · Cited by 121
Kay, C., Wang, R., Kirkby, M., & Man, S. M. (2020) · Immunological Reviews · doi:10.1111/imr.12906 · Cited by 97
Metadata
- Authors
- Liu, R., Truax, A. D., Chen, L., Hu, P., Li, Z., Chen, J., Song, C., Chen, L., & Ting, J. P.-Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-09-10
- Volume
- 6
- Issue
- 32
- Pages
- 33456-33469
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2219295994
- Cited by
- 118
- References
- 8
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.